Oncogene - Table of Contents alert Volume 37 Issue 15

If you are unable to see the message below, click here to view.

Advertisement RNA-seq has become much, much simpler  New CATS RNA-seq library preparation  Start-to-finish library preparation in 5 hours - and only 30 minutes hands-on time. Innovative "CATS" technology for reliable library prep down to only 10 picograms input.  Proven to detect more transcripts than any other commercial method -- guaranteed. Learn more TABLE OF CONTENTS Volume 37, Issue 15 In this issue Review Article Article Brief Communications Also new AOP Review Article Wild-type and mutated IDH1/2 enzymes and therapy responses Remco J. Molenaar, Jaroslaw P. Maciejewski, Johanna W. Wilmink & Cornelis J. F. van Noorden Oncogene 2018 37 :1949 - 1960; January 25, 2018; 10.1038/s41388-017-0077-z Abstract | Full Text Article Hypoxia induces miR-153 through the IRE1a-XBP1 pathway to fine tune the HIF1a/VEGFA axis in breast cancer angiogenesis Huichun Liang, Ji Xiao, Zhongmei Zhou, Jiao Wu, Fei Ge et al. Oncogene 2018 37 :1961 - 1975; January 25, 2018; 10.1038/s41388-017-0089-8 Abstract | Full Text PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation Angela Russo, Austin A. Czarnecki, Matthew Dean, Dimple A. Modi, Daniel D. Lantvit et al. Oncogene 2018 37 :1976 - 1990; January 25, 2018; 10.1038/s41388-017-0097-8 Abstract | Full Text PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma Jason A. Hanna, Matthew R. Garcia, Alicia Lardennois, Patrick J. Leavey, Dino Maglic et al. Oncogene 2018 37 :1991 - 2007; January 25, 2018; 10.1038/s41388-017-0081-3 Abstract | Full Text Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer Alacoque L. Browne, Sara Charmsaz, Damir Varešlija, Ailis Fagan, Nicola Cosgrove et al. Oncogene 2018 37 :2008 - 2021; January 25, 2018; 10.1038/s41388-017-0042-x Abstract | Full Text Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer Lucy Ireland, Almudena Santos, Fiona Campbell, Carlos Figueiredo, Dean Hammond et al. Oncogene 2018 37 :2022 - 2036; January 25, 2018; 10.1038/s41388-017-0115-x Abstract | Full Text Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production Hiroyasu Konno, Shota Yamauchi, Anders Berglund, Ryan M. Putney, James J. Mulé et al. Oncogene 2018 37 :2037 - 2051; January 25, 2018; 10.1038/s41388-017-0120-0 Abstract | Full Text CHTM1, a novel metabolic marker deregulated in human malignancies Mansi Babbar, Ying Huang, Jie An, Steve K. Landas & M. Saeed Sheikh Oncogene 2018 37 :2052 - 2066; January 26, 2018; 10.1038/s41388-017-0051-9 Abstract | Full Text Brief Communications ROS release by PPARß/d-null fibroblasts reduces tumor load through epithelial antioxidant response Eddie Han Pin Tan, Ming Keat Sng, Ivan Shun Bo How, Jeremy Soon Kiat Chan, Jiapeng Chen et al. Oncogene 2018 37 :2067 - 2078; January 25, 2018; 10.1038/s41388-017-0109-8 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.